Animal Model Market Size, Share, Growth Analysis, By Type(Pigs, Cats, and Mice), By Application(Research and Development, Production, and Quality Control), By End-use(Pharmaceutical & Biotechnology Companies, Academic Research Institute, Contract Research Organization), By Region - Industry Forecast 2025-2032

The global animal model market is highly competitive and comprises of several key players vying for market share. These companies engage in extensive research and development activities to develop innovative animal models and services to cater to the evolving needs of the pharmaceutical, biotechnology, and academic research sectors. Additionally, strategic collaborations, mergers, and acquisitions are commonly observed in the market as companies aim to strengthen their market presence and expand their product portfolios. The competitive landscape of the animal model market is characterized by intense competition, technological advancements, and a focus on customer-centric solutions. Market players strive to differentiate themselves through high-quality products, comprehensive service offerings, and strong customer support. With the growing demand for reliable and predictive animal models in drug discovery and development, these companies continue to play a crucial role in driving advancements in biomedical research and contributing to the overall growth of the animal model market.

Animal model Market Top Player’s Company Profiles

• Charles River Laboratories International Inc. (US)

• Envigo (US)

• The Jackson Laboratory (US)

• Taconic Biosciences Inc. (US)

• genOway SA (France)

• Horizon Discovery Group plc (UK)

• TransGenic Inc. (Japan)

• Crown Bioscience Inc. (US)

• Janvier Labs (France)

• Laboratory Corporation of America Holdings (US)

• Harbour Antibodies BV (Netherlands)

• Eurofins Scientific (Luxembourg)

• Biocytogen LLC (US)

• Transnetyx Inc. (US)

• Ingenious Targeting Laboratory (US)

• Charles River Japan (Japan)

• Cyagen Biosciences Inc. (US)

• Ozgene Pty Ltd (Australia)

• Hera Biolabs Inc. (US)

• Pharmaron Beijing Co., Ltd. (China)

Animal model Market Recent Development

• In order to differentiate antibody-drug R&D from preclinical models and services (BioMice), Biocytogen formed two business divisions in August 2023. 
• Merck strengthened its immunology program in April 2023 when it acquired Prometheus Biosciences, Inc. 
• CareDx and Miromatrix established an exclusive collaboration in April 2023 to further research on bioengineered organs for transplantation into humans. 
• AstraZeneca successfully completed the purchase of CinCor Pharma, Inc. (CinCor) in February 2023. CinCor is a clinical-stage biopharmaceutical business based in the US that focuses on developing innovative medicines for chronic kidney disease and resistant and uncontrolled hypertension.